Cell-of-origin of diffuse large B-cell lymphomas determined by the Lymph2Cx assay: better prognostic indicator than Hans algorithm

Diffuse large B-cell lymphomas (DLBCLs) are clinically heterogeneous and need a biomarker that can predict the outcome of treatments accurately. To assess the prognostic significance of the cell-of-origin type for DLBCLs, we applied the Lymph2Cx assay using a NanoString gene expression platform on f...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoon, Nara, Ahn, Soomin, Yoo, Hae Yong, Kim, Suk Jin, Kim, Won Seog, Ko, Young Hyeh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5400642/
https://www.ncbi.nlm.nih.gov/pubmed/28423544
http://dx.doi.org/10.18632/oncotarget.15782

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5400642/
https://www.ncbi.nlm.nih.gov/pubmed/28423544
http://dx.doi.org/10.18632/oncotarget.15782

Ejemplares similares